These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 28500751)

  • 1. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
    Whitwell JL; Höglinger GU; Antonini A; Bordelon Y; Boxer AL; Colosimo C; van Eimeren T; Golbe LI; Kassubek J; Kurz C; Litvan I; Pantelyat A; Rabinovici G; Respondek G; Rominger A; Rowe JB; Stamelou M; Josephs KA;
    Mov Disord; 2017 Jul; 32(7):955-971. PubMed ID: 28500751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.
    Grijalva RM; Pham NTT; Huang Q; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Weigand SD; Ahlskog JE; Dickson DW; Josephs KA; Whitwell JL
    Mov Disord; 2022 Apr; 37(4):702-712. PubMed ID: 34970796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Perspectives in Radiological and Radiopharmaceutical Hybrid Imaging in Progressive Supranuclear Palsy: A Systematic Review.
    Strobel J; Müller HP; Ludolph AC; Beer AJ; Sollmann N; Kassubek J
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
    Höglinger GU; Respondek G; Stamelou M; Kurz C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Nilsson C; Whitwell JL; Arzberger T; Englund E; Gelpi E; Giese A; Irwin DJ; Meissner WG; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Antonini A; Bhatia KP; Bordelon Y; Compta Y; Corvol JC; Colosimo C; Dickson DW; Dodel R; Ferguson L; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris HR; Nestor P; Oertel WH; Poewe W; Rabinovici G; Rowe JB; Schellenberg GD; Seppi K; van Eimeren T; Wenning GK; Boxer AL; Golbe LI; Litvan I;
    Mov Disord; 2017 Jun; 32(6):853-864. PubMed ID: 28467028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
    Orlandi F; Carlos AF; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Stephens YC; Schwarz CG; Senjem ML; Jack CR; Agosta F; Filippi M; Dickson DW; Josephs KA; Whitwell JL
    Brain Commun; 2024; 6(2):fcae113. PubMed ID: 38660629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria.
    Martí-Andrés G; van Bommel L; Meles SK; Riverol M; Valentí R; Kogan RV; Renken RJ; Gurvits V; van Laar T; Pagani M; Prieto E; Luquin MR; Leenders KL; Arbizu J
    Mov Disord; 2020 Nov; 35(11):2009-2018. PubMed ID: 32822512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic covariance pattern analysis outperforms visual reading of
    Buchert R; Wegner F; Huppertz HJ; Berding G; Brendel M; Apostolova I; Buhmann C; Dierks A; Katzdobler S; Klietz M; Levin J; Mahmoudi N; Rinscheid A; Rogozinski S; Rumpf JJ; Schneider C; Stöcklein S; Spetsieris PG; Eidelberg D; Wattjes MP; Sabri O; Barthel H; Höglinger G;
    Mov Disord; 2023 Oct; 38(10):1901-1913. PubMed ID: 37655363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Loss in Primary Tauopathies Revealed by [
    Holland N; Jones PS; Savulich G; Wiggins JK; Hong YT; Fryer TD; Manavaki R; Sephton SM; Boros I; Malpetti M; Hezemans FH; Aigbirhio FI; Coles JP; O'Brien J; Rowe JB
    Mov Disord; 2020 Oct; 35(10):1834-1842. PubMed ID: 32652635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
    Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
    JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo binding of a tau imaging probe, [
    Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
    Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.
    Nigro S; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Augimeri A; Quattrone A; Morelli M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2020 Jun; 35(6):976-983. PubMed ID: 32092195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes.
    Wattjes MP; Huppertz HJ; Mahmoudi N; Stöcklein S; Rogozinski S; Wegner F; Klietz M; Apostolova I; Levin J; Katzdobler S; Buhmann C; Quattrone A; Berding G; Brendel M; Barthel H; Sabri O; Höglinger G; Buchert R;
    Mov Disord; 2023 Oct; 38(10):1891-1900. PubMed ID: 37545102
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
    Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.